Nicholas Vardy
Bet on the ‘Google of Russia’
Stock markets across the globe resumed their upward trend last week with the S&P 500 rising 2.32% and the NASDAQ up 2.86%. The MCSI Emerging Markets Index also ended the week 2.40% higher. Big gainers in your Bull Market Alert portfolio included Thermo Fisher Scientific, Inc. (TMO), which jumped 5.07%. Recall that you sold half […]
Celebrate Valentine’s Day With Triple-Digit Percentage Gains
Your bet on Thermo Fisher Scientific (TMO) continues to rally, breaking out to yet another record high. With your March $115 call options up by 105.95%, sell your remaining options to book triple-digit percentage gains in just 10 trading days. Hold on to the stock for now, and I may recommend new options on this […]
Book 67.86% Gains in Medical Options
With the U.S. market rebounding strongly over the past few trading days, your bet on medical devices manufacturer Thermo Fisher Scientific (TMO) has also rallied sharply, breaking out to a new record high. With your March $115 call options (TMO140322C00115000) now up 67.86%, sell half of your options here to book these big gains. Hold […]
How to ‘Double Your Dividends’ in 2014’s Volatile Market
A handful of income-generating investments — through a combination of income and capital gains — have already generated big gains barely a month and a half into the volatile New Year.
Back into Spain with a Unique Medical Play
Global stock markets stabilized last week with the Dow Jones up 0.61% and the S&P 500 rising 0.81%. The MCSI Emerging Markets Index also recovered after a sharp sell-off by ending the week up 1.41%. Your Bull Market Alert positions were considerably more volatile — fortunately, mostly to the upside. Last week’s recommendations Thermo Fisher […]
Holding on Tight in a ‘Sloppy’ Market
It was a difficult and volatile week in the U.S. markets last week, as the Dow Jones fell 3.03% and the S&P 500 pulled back 2.08%. The MCSI Emerging Markets Index actually held up better than U.S. markets by ending the week down only 1.23%. Big gainers in your Alpha Investor Letter portfolio included the […]